Zero tolerance for healthcare-associated MRSA bacteraemia: Is it realistic?

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 8, 2014, Pages 2238-2245

  Török, M Estée ^a,b,c   Harris, Simon R ^d   Cartwright, Edward J P ^a,c   Raven, Kathy E ^a   Brown, Nicholas M ^b,c   Allison, Michael E D ^b   Greaves, Daniel ^b   Quail, Michael A ^d   Limmathurotsakul, Direk ^e   Holden, Matthew T G ^d   Parkhill, Julian ^d   Peacock, Sharon J ^a,b,c,d,e  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Methicillin resistant staphylococcus aureus; Outbreak; Whole genome sequencing

Indexed keywords

CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; OXACILLIN; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GENOME; BACTERIUM ISOLATE; DNA SEQUENCE; GENE SEQUENCE; GERIATRIC HOSPITAL; HEALTH SERVICE; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEPHROLOGY; NONHUMAN; PATIENT REFERRAL; PHYLOGENETIC TREE; ROOT CAUSE ANALYSIS; ZERO TOLERANCE; BACTERIUM IDENTIFICATION; CROSS INFECTION; END STAGE LIVER DISEASE; EPIDEMIC; GENETICS; HEALTH CARE DELIVERY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MORTALITY; MULTILOCUS SEQUENCE TYPING; NUCLEOTIDE SEQUENCE; PENICILLIN RESISTANCE; PHYLOGENY; STANDARDS; STAPHYLOCOCCAL INFECTIONS; TRANSMISSION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; BASE SEQUENCE; CROSS INFECTION; DELIVERY OF HEALTH CARE; DISEASE OUTBREAKS; DNA, BACTERIAL; END STAGE LIVER DISEASE; HUMANS; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS;

EID: 84904564235     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku128     Document Type: Article

References (30)

1. Department of Health. Clean, Safe Care: Reducing Infection and Saving Lives. London: Department of Health, 2008.
2. Department of Health. Saving Lives: Reducing Infection, Delivering Clean and Safe Care. London: Department of Health, 2007.
3. Public Health England. Results from the Mandatory Surveillance of MRSA Bacteraemia. 2013. http://www.hpa.org.uk/Topics/InfectiousDiseases/ InfectionsAZ/StaphylococcusAureus/EpidemiologicalData/Mandatory Surveillance/staphquarterlyreportingresults/ (17 March 2014, date last accessed).
4. Department of Health. Essential Steps to Safe, Clean Care. London: Department of Health, 2006.
5. National Patient Safety Agency. The Full Guide to Implementing the CleanYourHands Campaign in Your Trust. London: National Patient Safety Agency, 2004.
6. Department of Health. Winning Ways: Working Together to Reduce Healthcare Associated Infection in England. Report from the Chief Medical Officer. London: Department of Health, 2003.
7. Department of Health. Towards Cleaner Hospitals and Lower Rates of Infection: A Summary of Action. London: Department of Health, 2004.
8. Duerden BI. Responsibility for managing healthcare-associated infections: where does the buck stop? J Hosp Infect 2009; 73: 414-7.
9. Department of Health. The Operating Framework for the NHS in England 2012/13. London: Department of Health, 2011.
10. Dennis N, Erdos G. Cultures and Crimes: Policing in Four Nations. 1st edn. London: Civitas: Institute for the Study of Civil Society, 2005.
11. Arvaniti V, D'Amico G, Fede G et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010; 139: 1246-56.
12. Campillo B, Dupeyron C, Richardet JP. Epidemiology of hospitalacquired infections in cirrhotic patients: effect of carriage of methicillinresistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect 2001; 127: 443-50.
13. Campillo B, Richardet JP, Kheo T et al. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis 2002; 35: 1-10.
14. Desai D, Desai N, Nightingale P et al. Carriage of methicillin-resistant Staphylococcus aureus is associated with an increased risk of infection after liver transplantation. Liver Transpl 2003; 9: 754-9.
15. Chang FY, Singh N, Gayowski T et al. Staphylococcus aureus nasal colonization in patients with cirrhosis: prospective assessment of association with infection. Infect Control Hosp Epidemiol 1998; 19: 328-32.
16. Park HJ, Lee YM, Bang KM et al. Clinical significance of Staphylococcus aureus bacteremia in patients with liver cirrhosis. Eur J Clin Microbiol Infect Dis 2012; 31: 3309-16.
17. Cambridge University Hospitals NHS Foundation Trust. Infection Control Annual Report 2012-2013. http://www.cuh.org.uk/cms/sites/ default/files/FINAL%20DRAFT%20Infection%20Control%20Annual%20 Report%202012-13%20version%20281013.pdf (17 March 2014, date last accessed).
18. Köser CU, Holden MT, Ellington MJ et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. New Engl J Med 2012; 366: 2267-75.
19. Holden MT, Hsu LY, Kurt K et al. A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res 2013; 23: 653-64.
20. Fernandez J, Navasa M, Gomez J et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-8.
21. Fernandez J, Gustot T. Management of bacterial infections in cirrhosis. J Hepatol 2012; 56 Suppl 1: S1-12.
22. Gould FK, Brindle R, Chadwick PR et al. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. J Antimicrob Chemother 2009; 63: 849-61.
23. Gustot T, Felleiter P, Pickkers P et al. Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study. Liver Int 2014; doi:10.1111/liv.12520.
24. Department of Health. Screening for Methicillin-resistant Staphylococcus aureus (MRSA) Colonisation. A Strategy for NHS Trusts: A Summary of Best Practice. London: Department of Health, 2007.
25. Ammerlaan HS, Kluytmans JA, Wertheim HF et al. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009; 48: 922-30.
26. Ammerlaan HS, Kluytmans JA, Berkhout H et al. Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline. J Antimicrob Chemother 2011; 66: 2409-17.
27. Loeb MB, Main C, Eady A et al. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 2003; issue 4: CD003340.
28. Shinefield H, Black S, Fattom A et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. New Engl J Med 2002; 346: 491-6.
29. Fowler VG, Allen KB, Moreira ED et al. Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA 2013; 309: 1368-78.
30. Jansen KU, Girgenti DQ, Scully IL et al. Vaccine review: 'Staphylococcus aureus vaccines: problems and prospects'. Vaccine 2013; 31: 2723-30.